Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Buonomo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|May 2, 2022
Delayed-onset cutaneous eruption associated with lenalidomide in setting of multiple myelomaMichele Buonomo, Gowri Kabbur, Najla El Jurdi, et al.
Dermatology Online Journal|March 13, 2024
A case series of hydroxychloroquine exacerbating the dermatomyositis rashKatelyn Rypka, Michele Buonomo, Connor Buechler, et al.
JAMA Dermatology|November 3, 2021
Importance of Supplemental Patch Testing Beyond a Screening Series for Patients With Dermatitis: The North American Contact Dermatitis Group ExperienceErin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 27, 2021
Patch Testing to Ethylhexylglycerin: The North American Contact Dermatitis Group Experience, 2013-2018Erin M Warshaw, Michele Buonomo, Howard I Maibach, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 6, 2021
Patch Testing to Methyldibromoglutaronitrile/Phenoxyethanol: North American Contact Dermatitis Group Experience, 1994-2018Erin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Contact Dermatitis|April 12, 2021
Patch testing with sodium disulfite: North American Contact Dermatitis Group experience, 2017 to 2018Erin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|May 2, 2022
Delayed-onset cutaneous eruption associated with lenalidomide in setting of multiple myelomaMichele Buonomo, Gowri Kabbur, Najla El Jurdi, et al.
Dermatology Online Journal|March 13, 2024
A case series of hydroxychloroquine exacerbating the dermatomyositis rashKatelyn Rypka, Michele Buonomo, Connor Buechler, et al.
JAMA Dermatology|November 3, 2021
Importance of Supplemental Patch Testing Beyond a Screening Series for Patients With Dermatitis: The North American Contact Dermatitis Group ExperienceErin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 27, 2021
Patch Testing to Ethylhexylglycerin: The North American Contact Dermatitis Group Experience, 2013-2018Erin M Warshaw, Michele Buonomo, Howard I Maibach, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 6, 2021
Patch Testing to Methyldibromoglutaronitrile/Phenoxyethanol: North American Contact Dermatitis Group Experience, 1994-2018Erin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Contact Dermatitis|April 12, 2021
Patch testing with sodium disulfite: North American Contact Dermatitis Group experience, 2017 to 2018Erin M Warshaw, Michele Buonomo, Joel G DeKoven, et al.
Pageof 1